Human samples | Examined particles | Unilamellar | Bi- and trilamellar | Multicompartmental | Condition | Ref. |
---|---|---|---|---|---|---|
Cerebrospinal fluid | 75 | 54.4% | 8.1% | 36.5%* | Parkinson’s Disease (PD) | [76] |
Cerebrospinal fluid | 85 | 82.3% | 9.4% | 8.3% | Other neurological diseases | [76] |
Cerebrospinal Fluid | Â | 40% | 60% | NA | Traumatic brain injury | [91] |
Ejaculates | 1110 | 76.9% | 19.6% | 3.5% | Normal conditions | [77] |
Mast cell | 1724# | 81.7% | 1.1% | 1.3% | Conditioned medium | [80] |
Myelinosome-like vesicles in seminal plasma |  | 59% | 20–30% | < 1% | Normal conditions | [88] |
Plasma\total Blood § |  | 15%\20% | 70%\81% | 5%\10% | Diagnostic/prognostic breast cancer | [92] |
Visceral adipose tissue (VAT) \ subcutaneous adipose tissue (SAT)‡ |  | 65.40%\84.70% | 22.40% \8.10% | 8.60% \4.20% | Obesity and type 2 diabetes mellitus | [130] |